Postoperative Radiotherapy in Advanced Stage Squamous Cell Carcinoma Requiring Maxillectomy
Otolaryngology–Head and Neck Surgery · 2024
DOI: 10.1002/ohn.896 ↗Kurz gefasst
Fachartikel in der Zeitschrift Otolaryngology–Head and Neck Surgery, 2024. Verfasst von Randall J Harley und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Maxilla, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
Objective
To evaluate whether postoperative radiotherapy (PORT) improves survival among patients who received maxillectomy for pT4aN0 maxillary gingival or hard palate squamous cell carcinoma (SCC) with respect to tumor size. Study Design Retrospective analysis.
Setting
National Cancer Database from 2004 to 2019.
Methods
Included adult patients who received maxillectomy (partial, subtotal, or total) and neck dissection for treatment‐naive margin negative pT4aN0 SCC of the maxillary gingiva or hard palate. Adjusted for age, gender, race, insurance status, income, education, urban/rural, facility type, region, comorbidity index, tumor grade, and tumor extension. Inverse probability weights were incorporated into a multivariable Cox proportional hazards model. A priori post hoc subgroup analysis was performed according to tumor size.
Results
We included 416 patients who underwent maxillectomy for pT4aN0 SCC of the maxillary gingiva or hard palate (mean [standard deviation] age, 71.5 [11.3] years; male, 190 [45.7%]; tumor size 2 cm, 362 [87%]). Overall, 49.3% of patients received PORT (205 patients). PORT was associated with a 50% improvement in survival compared to surgery alone (adjusted hazard ratio [aHR], 0.50; 95% confidence interval [95% CI], 0.32‐0.81). On subgroup analysis, PORT was associated with improved survival for tumors 2 cm (aHR, 0.47; 95% CI, 0.29‐0.77), but not for tumors < 2 cm (aHR, 1.15; 95% CI, 0.33‐4.08).
Conclusion
The vast majority of patients with pT4aN0 bone‐invading SCC of the maxillary gingiva and hard palate benefit from PORT. Patients with tumors < 2 cm did not demonstrate a survival benefit from adjuvant treatment, suggesting that bony invasion alone may not be sufficient criteria for treatment escalation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Department of Otolaryngology-Head and Neck Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
- Department of Radiation Oncology, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.
ORCID-Profile: Randall J Harley
Zitieren
APA
Harley, R. J., Spector, M. E., Wilke, C. T., & Sridharan, S. (2024). Postoperative Radiotherapy in Advanced Stage Squamous Cell Carcinoma Requiring Maxillectomy. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.896
Vancouver
Harley RJ, Spector ME, Wilke CT, Sridharan S. Postoperative Radiotherapy in Advanced Stage Squamous Cell Carcinoma Requiring Maxillectomy. Otolaryngology–Head and Neck Surgery. 2024. doi:10.1002/ohn.896
BibTeX
@article{Harley2024,
author = {Harley, Randall J and Spector, Matthew E and Wilke, Christopher T and Sridharan, Shaum},
title = {Postoperative Radiotherapy in Advanced Stage Squamous Cell Carcinoma Requiring Maxillectomy},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2024},
doi = {10.1002/ohn.896}
}
EUVIMED